Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Topical treatments for hair loss can be effective but need careful safety evaluation.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

People with alopecia who are more resilient tend to feel less stressed.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

The study concluded that the arachidonic acid pathway and the protein KRT79 play a role in determining the fineness of cashmere.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

New gene variants linked to a rare inherited hair loss disorder were found in three Chinese families.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Genetic testing is crucial for diagnosing congenital atrichia, a rare condition causing irreversible hair loss.

Topical latanoprost doesn't effectively regrow hair in severe eyebrow alopecia areata cases.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

FFA's causes may include environmental triggers and genetic factors.

Different hair growth problems are caused by genetic issues or changes in hair growth cycles, and new treatments are being developed.

Graying hair happens due to aging and might be delayed by new treatments.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

FGF5 gene mutations cause unusually long eyelashes by affecting hair growth regulation.

Lash ptosis is more common and severe in people with congenital eyelid droop than in those with acquired eyelid droop or without eyelid droop.

A woman with an unusual pattern of hair loss was confirmed to have Frontal Fibrosing Alopecia and treated with specific medications.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Alopecia areata greatly affects people's life quality, mental health, and work life.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.